These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18377980)

  • 1. Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors.
    Manickam DS; Hirata A; Putt DA; Lash LH; Hirata F; Oupický D
    Biomaterials; 2008 Jun; 29(17):2680-8. PubMed ID: 18377980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors.
    Manickam DS; Li J; Putt DA; Zhou QH; Wu C; Lash LH; Oupický D
    J Control Release; 2010 Jan; 141(1):77-84. PubMed ID: 19720098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
    Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
    J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A; Agrawal KC
    Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
    Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
    Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyplex gene delivery modulated by redox potential gradients.
    Soundara Manickam D; Oupický D
    J Drug Target; 2006 Sep; 14(8):519-26. PubMed ID: 17050118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements of antisense oligonucleotides in treatment of breast cancer.
    Yang SP; Song ST; Song HF
    Acta Pharmacol Sin; 2003 Apr; 24(4):289-95. PubMed ID: 12676065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-Stabilized Redox-Sensitive Nanoassembly for Chemo-Gene Therapy and Dual T1/T2 MR Imaging in Drug-Resistant Breast Cancer Cells.
    Rajendrakumar SK; Venu A; Revuri V; George Thomas R; Thirunavukkarasu GK; Zhang J; Vijayan V; Choi SY; Lee JY; Lee YK; Jeong YY; Park IK
    Mol Pharm; 2019 May; 16(5):2226-2234. PubMed ID: 30924664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
    Vetter VC; Wagner E
    J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
    Mercatante DR; Mohler JL; Kole R
    J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
    Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
    de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
    Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
    J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
    Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Targeting Gene Vector for Visual Tracking of Bcl-2 siRNA Transfection and Anti-Tumor Therapy.
    Sun W; Liu XY; Ma LL; Lu ZL
    ACS Appl Mater Interfaces; 2020 Mar; 12(9):10193-10201. PubMed ID: 32045197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier.
    Hu Y; Liu N; Cheng B; Tan Y; Wen L; Yuan H; Hu F
    Oncotarget; 2016 Dec; 7(50):83258-83269. PubMed ID: 27825127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis.
    Takahashi M; Saito H; Okuyama T; Miyashita T; Kosuga M; Sumisa F; Yamada M; Ebinuma H; Ishii H
    J Hepatol; 1999 Aug; 31(2):315-22. PubMed ID: 10453946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells.
    Honda T; Coppola S; Ghibelli L; Cho SH; Kagawa S; Spurgers KB; Brisbay SM; Roth JA; Meyn RE; Fang B; McDonnell TJ
    Cancer Gene Ther; 2004 Apr; 11(4):249-55. PubMed ID: 15002033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.